Cargando…

The Chemopreventive Role of β-Elemene in Cholangiocarcinoma by Restoring PCDH9 Expression

BACKGROUND: β-Elemene, an effective anticancer component isolated from the Chinese herbal medicine Rhizoma Zedoariae, has been proved to have therapeutic potential against multiple cancers by extensive clinical trials and experimental research. However, its preventive role in cholangiocarcinoma (CCA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Qing, Shi, Xintong, Pan, Yating, Liao, Xinyi, Xu, Jiahua, Gu, Xiaoqiang, Yu, Wenlong, Chen, Ying, Yu, Guanzhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314746/ https://www.ncbi.nlm.nih.gov/pubmed/35903688 http://dx.doi.org/10.3389/fonc.2022.874457

Ejemplares similares

Avasimibe Dampens Cholangiocarcinoma Progression by Inhibiting FoxM1-AKR1C1 Signaling
por: Gao, Yunshu, et al.
Publicado: (2021)

PCDH9 suppresses melanoma proliferation and cell migration
por: Zhang, Jiaojiao, et al.
Publicado: (2022)

Circ_0084043-miR-134-5p axis regulates PCDH9 to suppress melanoma
por: Cai, Guiyue, et al.
Publicado: (2022)

PCDH20 inhibits esophageal squamous cell carcinoma proliferation and migration by suppression of the mitogen-activated protein kinase 9/AKT/β-catenin pathway
por: Ning, Yijiao, et al.
Publicado: (2022)

Paclitaxel Restores Sensitivity to Chemotherapy in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma
por: Massa, Annamaria, et al.
Publicado: (2022)

Elémens de Chimie
Publicado: (1836)

The prognostic potential and oncogenic effects of PRR11 expression in hilar cholangiocarcinoma
por: Chen, Ying, et al.
Publicado: (2015)

Beta-Elemene Reduces the Malignancy of Non-Small Cell Lung Cancer by Enhancing C3orf21 Expression
por: Cai, Hu, et al.
Publicado: (2021)

ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1
por: Jiao, Xiaodong, et al.
Publicado: (2018)

Chemoprevention for Breast Cancer
por: Pruthi, Sandhya, et al.
Publicado: (2015)

Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy
por: Zhai, Bingtao, et al.
Publicado: (2018)

Dual inhibition of PCDH9 expression by miR-215-5p up-regulation in gliomas
por: Wang, Chunlin, et al.
Publicado: (2016)

Importance of Normalization of Carbohydrate Antigen 19-9 in Patients With Intrahepatic Cholangiocarcinoma
por: Li, Hui, et al.
Publicado: (2021)

Progress in Radiotherapy for Cholangiocarcinoma
por: Wang, Ningyu, et al.
Publicado: (2022)

Comparative characterization of PCDH19 missense and truncating variants in PCDH19-related epilepsy
por: Shibata, Mami, et al.
Publicado: (2020)

Élemens de pathologie chirurgicale

Interventional Treatment for Cholangiocarcinoma
por: Li, Hang, et al.
Publicado: (2021)

Case Report: Primary lymphoepithelioma-like intrahepatic cholangiocarcinoma
por: Liu, Fei, et al.
Publicado: (2023)

PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma
por: Yu, Guanzhen, et al.
Publicado: (2015)

Extract of Marsdenia tenacissima (Roxb.) Moon [Apocynaceae] Suppresses Hepatocellular Carcinoma by Inhibiting Angiogenesis
por: Pan, Yating, et al.
Publicado: (2022)

COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs
por: Gurpinar, Evrim, et al.
Publicado: (2013)

Chemopreventive Potential of Dietary Nanonutraceuticals for Prostate Cancer: An Extensive Review
por: Chopra, Hitesh, et al.
Publicado: (2022)

Lnc-PCDH9-13:1 Is a Hypersensitive and Specific Biomarker for Early Hepatocellular Carcinoma
por: Xie, Zijun, et al.
Publicado: (2018)

β-elemene combined with temozolomide in treatment of brain glioma
por: Zhang, Xiaomin, et al.
Publicado: (2021)

Brain calcifications and PCDH12 variants
por: Nicolas, Gaël, et al.
Publicado: (2017)

Proposal for a new N-stage classification system for intrahepatic cholangiocarcinoma
por: Liao, Shan, et al.
Publicado: (2023)

The REDUCE metagram: a comprehensive prediction tool for determining the utility of dutasteride chemoprevention in men at risk for prostate cancer
por: Nguyen, Carvell T., et al.
Publicado: (2012)

Preoperative Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Nomogram Based on Ultrasonographic Features and Clinical Indicators
por: Chen, Yanling, et al.
Publicado: (2022)

An Immunity-Related Gene Model Predicts Prognosis in Cholangiocarcinoma
por: Guo, Han, et al.
Publicado: (2022)

Synergy of Losartan and chemotherapy for patients with cholangiocarcinoma: A propensity score-matched analysis
por: Li, Qing, et al.
Publicado: (2022)

A Nomogram Model to Predict Early Recurrence of Patients With Intrahepatic Cholangiocarcinoma for Adjuvant Chemotherapy Guidance: A Multi-Institutional Analysis
por: Li, Qi, et al.
Publicado: (2022)

Organoids Increase the Predictive Value of in vitro Cancer Chemoprevention Studies for in vivo Outcome
por: Njoroge, Rose N., et al.
Publicado: (2019)

Epigenetics-Associated Risk Reduction of Hematologic Neoplasms in a Nationwide Cohort Study: The Chemopreventive and Therapeutic Efficacy of Hydralazine
por: Yang, Bing-Heng, et al.
Publicado: (2022)

Characteristic of Perineural Invasion in Hilar Cholangiocarcinoma Based on Whole-Mount Histologic Large Sections of Liver
por: Wang, Si-Yuan, et al.
Publicado: (2022)

Development and Validation of a Nomogram for Differentiating Combined Hepatocellular Cholangiocarcinoma From Intrahepatic Cholangiocarcinoma
por: Wang, Tao, et al.
Publicado: (2020)

Elemene Nanoemulsion Inhibits Metastasis of Breast Cancer by ROS Scavenging
por: Han, Bo, et al.
Publicado: (2021)

Promising agents for chemoprevention of skin cancer
por: Stratton, S.P., et al.
Publicado: (2006)

Recurrent Intrahepatic Cholangiocarcinoma – Review
por: Bekki, Yuki, et al.
Publicado: (2021)

Mosaicism and incomplete penetrance of PCDH19 mutations
por: Liu, Aijie, et al.
Publicado: (2019)

The role of Pcdh10 in neurological disease and cancer
por: Zhen, Yilan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5n9t4h8pk4i54q8f1hvopk2gjm